- Home
- VNDA vs TEI Comparison
VNDA vs TEI Comparison
Compare VNDA & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- TEI
- Stock Information
- Founded
- VNDA 2002
- TEI 1993
- Country
- VNDA United States
- TEI United States
- Employees
- VNDA N/A
- TEI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- TEI Finance Companies
- Sector
- VNDA Health Care
- TEI Finance
- Exchange
- VNDA Nasdaq
- TEI Nasdaq
- Market Cap
- VNDA 237.9M
- TEI 256.5M
- IPO Year
- VNDA 2006
- TEI N/A
- Fundamental
- Price
- VNDA $4.33
- TEI $5.13
- Analyst Decision
- VNDA Strong Buy
- TEI
- Analyst Count
- VNDA 2
- TEI 0
- Target Price
- VNDA $16.50
- TEI N/A
- AVG Volume (30 Days)
- VNDA 754.6K
- TEI 142.4K
- Earning Date
- VNDA 05-07-2025
- TEI 01-01-0001
- Dividend Yield
- VNDA N/A
- TEI 10.51%
- EPS Growth
- VNDA N/A
- TEI N/A
- EPS
- VNDA N/A
- TEI N/A
- Revenue
- VNDA $198,772,000.00
- TEI N/A
- Revenue This Year
- VNDA $14.36
- TEI N/A
- Revenue Next Year
- VNDA $44.53
- TEI N/A
- P/E Ratio
- VNDA N/A
- TEI N/A
- Revenue Growth
- VNDA 3.18
- TEI N/A
- 52 Week Low
- VNDA $3.85
- TEI $4.35
- 52 Week High
- VNDA $6.75
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- VNDA 43.42
- TEI 44.18
- Support Level
- VNDA $4.27
- TEI $4.78
- Resistance Level
- VNDA $4.46
- TEI $5.20
- Average True Range (ATR)
- VNDA 0.22
- TEI 0.13
- MACD
- VNDA 0.01
- TEI -0.01
- Stochastic Oscillator
- VNDA 54.55
- TEI 50.72
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments and Money Market Funds.